Acro Biomedical (ACBM) Net Cash Flow Growth (3y) (2018 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | EQV Ventures Acquisition | 477.69 Mn | 477.69 Mn | - | - |
| 2 | Berto Acquisition | 316.66 Mn | 316.66 Mn | - | - |
| 3 | Centurion Acquisition | 311.94 Mn | 311.94 Mn | - | - |
| 4 | Churchill Capital Corp IX | 311.36 Mn | 311.36 Mn | - | - |
| 5 | Agriculture & Natural Solutions Acquisition | 301.94 Mn | 301.94 Mn | - | - |
| 6 | Siddhi Acquisition Corp (Cayman Islands) | 286.76 Mn | 286.76 Mn | - | - |
| 7 | Bold Eagle Acquisition | 276.06 Mn | 276.06 Mn | - | - |
| 8 | Cartesian Growth Corp III | 270.68 Mn | 270.68 Mn | - | - |
| 9 | Oyster Enterprises II Acquisition | 266.84 Mn | 266.84 Mn | - | - |
| 10 | Acro Biomedical | - | - | - | 72.08% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 72.08% |
| Sep 30, 2025 | 1.73% |
| Jun 30, 2025 | 91.33% |
| Mar 31, 2025 | -26.01% |
| Dec 31, 2024 | 84.41% |
| Sep 30, 2024 | 84.53% |
| Jun 30, 2024 | -84.05% |
| Mar 31, 2024 | -26.75% |
| Sep 30, 2023 | 66.63% |
| Jun 30, 2023 | 30.65% |
| Mar 31, 2023 | -36.95% |
| Dec 31, 2022 | -164.12% |
| Sep 30, 2022 | 28.32% |
| Jun 30, 2022 | -109.88% |
| Mar 31, 2022 | 108.43% |
| Dec 31, 2021 | -53.68% |
| Sep 30, 2021 | -159.85% |
| Jun 30, 2021 | 34.06% |
| Mar 31, 2021 | -76.21% |
| Sep 30, 2020 | -26.12% |
| Mar 31, 2020 | 32.57% |
| Dec 31, 2019 | -58.09% |
| Sep 30, 2019 | -55.51% |
| Jun 30, 2019 | -88.27% |
| Mar 31, 2019 | -65.77% |
| Dec 31, 2018 | 73.33% |
| Sep 30, 2018 | -31.69% |